Immunovia AB (publ) Short Interest Ratio and Short Volume

Short interest is the volume of Immunovia AB (publ) shares that have been sold short but have not yet been covered or closed out. As of December 31st, investors have sold 200 shares of IMMVF short. 0.00% of Immunovia AB (publ)'s shares are currently sold short. View details.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Immunovia AB (publ) currently has a short interest ratio of 2.0.

Immunovia AB (publ) saw a decrease in short interest in December. As of December 31st, there was short interest totaling 200 shares, a decrease of 98.7% from the previous total of 15,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Immunovia AB (publ)'s shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Immunovia AB (publ): Abattis Bioceuticals Corp. (0.00%), Alaric Co. (0.00%), Algernon Pharmaceuticals Inc. (0.00%), Almirall, S.A. (0.00%), Ascletis Pharma Inc. (0.00%), AXIM Biotechnologies, Inc. (0.00%), BerGenBio ASA (0.00%), Cannabics Pharmaceuticals Inc. (0.00%), Cerebain Biotech Corp. (0.00%), and Creative Medical Technology Holdings, Inc. (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

Short selling IMMVF is an investing strategy that aims to generate trading profit from Immunovia AB (publ) as its price is falling. To short Immunovia AB (publ) stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Immunovia AB (publ) will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Immunovia AB (publ) occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMMVF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMMVF, twice per month. The most recent reporting period available is December, 31 2020.